BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17968307)

  • 1. Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.
    Kanazawa H
    Med Sci Monit; 2007 Nov; 13(11):RA189-195. PubMed ID: 17968307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease.
    Kranenburg AR; de Boer WI; Alagappan VK; Sterk PJ; Sharma HS
    Thorax; 2005 Feb; 60(2):106-13. PubMed ID: 15681497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury.
    Lahm T; Crisostomo PR; Markel TA; Wang M; Lillemoe KD; Meldrum DR
    Shock; 2007 Jul; 28(1):4-14. PubMed ID: 17510598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.
    Cai S; Chen P; Zhang C; Chen JB; Wu J
    Respirology; 2009 Apr; 14(3):354-9. PubMed ID: 19341424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of alveolar cell apoptosis in COPD].
    Aoshiba K
    Nihon Rinsho; 2007 Apr; 65(4):629-32. PubMed ID: 17419379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.
    Thébaud B; Ladha F; Michelakis ED; Sawicka M; Thurston G; Eaton F; Hashimoto K; Harry G; Haromy A; Korbutt G; Archer SL
    Circulation; 2005 Oct; 112(16):2477-86. PubMed ID: 16230500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional significance of apoptosis in chronic obstructive pulmonary disease.
    Park JW; Ryter SW; Choi AM
    COPD; 2007 Dec; 4(4):347-53. PubMed ID: 18027162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The early responses of VEGF and its receptors during acute lung injury: implication of VEGF in alveolar epithelial cell survival.
    Mura M; Han B; Andrade CF; Seth R; Hwang D; Waddell TK; Keshavjee S; Liu M
    Crit Care; 2006; 10(5):R130. PubMed ID: 16968555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of pulmonary hypertension, but not emphysematous change, by breeding emphysema model mice at sea level.
    Fujita M; Ikegame S; Ye Q; Harada E; Ouchi H; Inoshima I; Watanabe K; Mason RJ; Nakanishi Y
    Cytokine; 2008 Mar; 41(3):286-92. PubMed ID: 18206385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of and the effect of smoking on vascular endothelial growth factor and induced nitric oxide synthase in lung tissues of chronic obstructive pulmonary disease patients].
    Huo JM; Chen JY; Kong YJ; Shi YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Aug; 30(8):573-6. PubMed ID: 17988548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors.
    Guan XJ; Song L; Han FF; Cui ZL; Chen X; Guo XJ; Xu WG
    J Cell Biochem; 2013 Feb; 114(2):323-35. PubMed ID: 22949406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New concepts in the pathogenesis and pathophysiology of COPD].
    Fira-Mladinescu O; Tudorache V; Mihăicută S; Muntean D
    Pneumologia; 2007; 56(1):24, 26-31. PubMed ID: 17491205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in circulating thrombomodulin levels with exercise in patients with chronic obstructive pulmonary disease.
    Kanazawa H; Asai K; Nomura S
    Respirology; 2007 Sep; 12(5):670-4. PubMed ID: 17875054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor in amyotrophic lateral sclerosis and other neurodegenerative diseases.
    Bogaert E; Van Damme P; Van Den Bosch L; Robberecht W
    Muscle Nerve; 2006 Oct; 34(4):391-405. PubMed ID: 16856151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications for vascular endothelial growth factor in the lung: friend or foe?
    Papaioannou AI; Kostikas K; Kollia P; Gourgoulianis KI
    Respir Res; 2006 Oct; 7(1):128. PubMed ID: 17044926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathomechanisms in chronic obstructive pulmonary disease (COPD)].
    Glaab T; Hohlfeld JM; Jörres RA; Krug N; Welte T
    Med Klin (Munich); 2006 Dec; 101(12):951-6. PubMed ID: 17171318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
    Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
    Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells.
    Dallas NA; Fan F; Gray MJ; Van Buren G; Lim SJ; Xia L; Ellis LM
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):433-41. PubMed ID: 17786539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current insights on the biology and clinical aspects of VEGF regulation.
    Birk DM; Barbato J; Mureebe L; Chaer RA
    Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.